Recce Pharmaceuticals Ltd (ASX: RCE) is pioneering the development and commercialisation of a new class of synthetic antibiotics with broad spectrum activity designed to address the urgent global health problem of antibiotic resistant superbugs.
Bristol-Myers Squibb
259 followers
Astellas Pharma
42 followers
NYU Langone Health
25 followers
West Pharmaceutical Services
8 followers
Curia Global
6 followers
AbbVie
275 followers
Navitus Health
3 followers
Xeris Pharmaceuticals
2 followers
Corcept Therapeutics
4 followers
Arthritis Knee Pain Centers
2 followers
Agiliti
7 followers
Explore companies